FindTrial
Sign In

Early non-invasive prediction of bronchopulmonary dysplasia in premature infants based on urinary 8-OHdG and NT-pro BNP detection

Early non-invasive prediction of bronchopulmonary dysplasia in premature infants based on urinary 8-OHdG and NT-pro BNP detection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057749
Enrollment
Unknown
Registered
2022-03-16
Start date
2022-03-20
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary Dysplasia (BPD)

Interventions

BPD group:None
Control group:None

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Gestational age <32 weeks, weight <1500g, hospitalized in neonatology department within 1 week after birth; 2. Single live births; 3. Parents sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Children who were discharged, abandoned treatment or died before the gestational age reached 36 weeks were corrected; 2. Cases with incomplete and unreliable clinical data and unclear medical history; 3. Severe congenital heart disease, chromosomal disease, genetic metabolic disease and other serious malformations.

Design outcomes

Primary

MeasureTime frame
8-hydroxydeoxyguanosine, 8-OHdG;N-terminal pro B-type natriuretic peptide, NT-pro BNP;—

Countries

China

Contacts

Public ContactFu Jianhua
liying58522@163.com+86 18940251830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026